LSA
AVXL icon

Leonteq Securities AG’s Anavex Life Sciences AVXL Stock Holding History

Leonteq Securities AG’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$9 – 1215
2022
Q4 		$9 Sell
1
-15,007
-100% -$160K ﹤0.01% 1277
2022
Q3 		$155K Sell
15,008
-362
-2% -$3.82K 0.01% 572
2022
Q2 		$154K Buy
15,370
+4,430
+40% +$42K 0.01% 599
2022
Q1 		$135K Buy
10,940
+5,726
+110% +$70.4K ﹤0.01% 671
2021
Q4 		$90.4K Sell
5,214
-356
-6% -$6.76K ﹤0.01% 792
2021
Q3 		$100K Buy
5,570
+2,570
+86% +$51.2K ﹤0.01% 719
2021
Q2 		$68.6K Hold
3,000
– – ﹤0.01% 789
2021
Q1 		$44.9K Buy
+3,000
New +$32.8K ﹤0.01% 798

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Leonteq Securities AG's AVXL Position: Q1 2023 in Review

Leonteq Securities AG sold out of Anavex Life Sciences (AVXL) in Q1 2023, closing a stake of 1 share — an estimated $9 sold.

Leonteq Securities AG first reported a position in AVXL in Q1 2021 and held it in 8 quarters. The position peaked at $155K in Q3 2022. 141 funds tracked by Wall St. Rank hold AVXL as of Q1 2023.

  • Leonteq Securities AG reported no remaining Anavex Life Sciences position as of Q1 2023 after selling out during the quarter.
  • Leonteq Securities AG sold 1 Anavex Life Sciences share in Q1 2023, an estimated $9.
  • Leonteq Securities AG first reported a position in Anavex Life Sciences in Q1 2021 and held it in 8 quarters.
  • Leonteq Securities AG's Anavex Life Sciences position peaked at $155K in Q3 2022.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2023.

Based on Leonteq Securities AG's 13F filing for Q1 2023, filed 11 Mar 2026.